Immunogenetics of type 1 diabetes mellitus

Molecular Aspects of Medicine

Volumn 42, Issue , 2015, Pages 42-60

  Morran, Michael P ^a   Vonberg, Andrew ^a   Khadra, Anmar ^b   Pietropaolo, Massimo ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Genetics; Immunology; Pathogenesis; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CATION TRANSPORT PROTEIN; GLUTAMATE DECARBOXYLASE; ICA512 AUTOANTIBODY; SLC30A8 PROTEIN, HUMAN;

CELLULAR IMMUNITY; GENETIC PREDISPOSITION; GENETICS; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX;

AUTOANTIBODIES; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MAJOR HISTOCOMPATIBILITY COMPLEX;

EID: 84928780572     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2014.12.004     Document Type: Review

References (178)

1. Achenbach P., Warncke K., Reiter J., Naserke H.E., Williams A.J., and Bingley P.J. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics Diabetes 53 2 2004 384 392
2. Alkanani A.K., Hara N., Gianani R., and Zipris D. Kilham rat virus-induced type 1 diabetes involves beta cell infection and intra-islet JAK-STAT activation prior to insulitis Virology 468-470C 2014 19 27
3. Allen C., Palta M., and D'Alessio D.J. Incidence and differences in urban-rural seasonal variation of type 1 (insulin-dependent) diabetes in Wisconsin Diabetologia 29 1986 629 633
4. Allen J.S., Pang K., Skowera A., Ellis R., Rackham C., and Lozanoska-Ochser B. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture Diabetes 58 1 2009 138 145
5. Aly T.A., Ide A., Jahromi M.M., Barker J.M., Fernando M.S., and Babu S.R. Extreme genetic risk for type 1A diabetes Proc. Natl. Acad. Sci. U.S.A. 103 38 2006 14074 14079
6. Atkinson M.A., and Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment Lancet 358 9277 2001 221 229
7. Atkinson M.A., Kaufman D.L., Newman D., Tobin A.J., and Maclaren N.K. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes J. Clin. Invest 91 1993 350 356
8. Awata T., Kurihara S., Iitaka M., Takei S., Inoue I., and Ishii C. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population Diabetes 47 1 1998 128 129
9. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases N. Engl. J. Med 347 12 2002 911 920
10. Baekkeskov S., Warnock G., Christie M., Rajotte R.V., Larsen P.M., and Fey S. Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis: unambiguous identification of 64K target antigen Diabetes 38 1989 1133 1141
11. Baekkeskov S., Aanstoot H., Christgau S., Reetz A., Solimena M.S., and Cascalho M. Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase Nature 347 1990 151 156
12. Bain S.C., Prins J.B., Hearne C.M., Rodrigues N.R., Rowe B.R., and Pritchard L.E. Insulin gene region-encoded susceptibility to type I diabetes is not restricted to HLA-DR4-positive individuals Nat. Genet 2 1992 212 215
13. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., and Erlich H.A. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes Nat. Genet 41 6 2009 703 707
14. Bell G.I., Karam J.H., and Rutter W.J. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene Proc. Natl. Acad. Sci. U.S.A. 78 1981 5759 5763
15. Bennett S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E., and Pritchard L.E. Susceptibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus Nat. Genet 9 1995 284 292
16. Bluestone J.A., and Boehmer H. Regulatory T cells Semin. Immunol 18 2 2006 77
17. Bluestone J.A., and Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr. Opin. Immunol 17 6 2005 638 642
18. Boitard C., Bendelac A., Richard M.F., Carnaud C., and Bach J.F. Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells Proc. Natl. Acad. Sci. U.S.A. 85 1988 9719 9723
19. Bonifacio E., Yu L., Williams A.K., Eisenbarth G.S., Bingley P.J., and Marcovina S.M. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia J. Clin. Endocrinol. Metab 95 7 2010 3360 3367
20. Bonner S.M., Pietropaolo S.L., Fan Y., Chang Y., Sethupathy P., and Morran M.P. Sequence variation in promoter of Ica1 gene, which encodes protein implicated in type 1 diabetes, causes transcription factor autoimmune regulator (AIRE) to increase its binding and down-regulate expression J. Biol. Chem 287 21 2012 17882 17893
21. Bottazzo G.F., Florin-Christensen A., and Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies Lancet 2 1974 1279 1282
22. Bottazzo G.F., Dean B.M., McNally J.M., Mackay E.H., Swift P.G.F., and Gamble D.R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis N. Engl. J. Med 313 1985 353 360
23. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., and Rostamkhani M. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes Nat. Genet 36 4 2004 337 338
24. Bottini N., Vang T., Cucca F., and Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases Semin. Immunol 18 4 2006 207 213
25. Brewer K.W., Parziale V.S., and Eisenbarth G.S. Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency N. Engl. J. Med 337 1997 202
26. Brown J.H., Jardetzky T.S., and Gorga J.C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 Nature 364 1993 33 39
27. Carcassi C., Trucco G., Trucco M., and Contu L. A new HLA-DR2 extended haplotype is involved in IDDM susceptibility Hum. Immunol 31 1991 159 164
28. Chatenoud L., Thervet E., Primo J., and Bach J.F. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice Proc. Natl. Acad. Sci. U.S.A. 91 1 1994 123 127
29. Chimienti F., Devergnas S., Favier A., and Seve M. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules Diabetes 53 9 2004 2330 2337
30. Concannon P., Rich S.S., and Nepom G.T. Genetics of type 1A diabetes N. Engl. J. Med 360 16 2009 1646 1654
31. Conrad B., Weidmann E., Trucco G., Rudert W.A., Ricordi C., and Rodriquez-Rilo H. Evidence for superantigen involvment in insulin-dependent diabetes mellitus etiology Nature 371 1994 351 355
32. Cooper J.D., Smyth D.J., Smiles A.M., Plagnol V., Walker N.M., and Allen J.E. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci Nat. Genet 40 12 2008 1399 1401
33. Cooper J.D., Howson J.M., Smyth D., Walker N.M., Stevens H., and Yang J.H. Confirmation of novel type 1 diabetes risk loci in families Diabetologia 55 4 2012 996 1000
34. Crawford F., Stadinski B., Jin N., Michels A., Nakayama M., and Pratt P. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse Proc. Natl. Acad. Sci. U.S.A. 108 40 2011 16729 16734
35. Cucca F., Dudbridge F., Loddo M., Mulargia A.P., Lampis R., and Angius E. The HLA-DPB1 - associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1 Diabetes 50 5 2001 1200 1205
36. Davey M.P., Meyer M.M., and Bakke A.C. T cell receptor Vb gene expression in monozygotic twins: discordance in CD8 subset and in disease states J. Immunol 152 1994 315 321
37. Delong T., Baker R.L., He J., Barbour G., Bradley B., and Haskins K. Diabetogenic T-cell clones recognize an altered peptide of chromogranin A Diabetes 61 12 2012 3239 3246
38. Devendra D., Jasinski J., Melanitou E., Nakayama M., Li M., and Hensley B. Interferon-alpha as a mediator of polyinosinic:polycytidylic acid-induced type 1 diabetes Diabetes 54 9 2005 2549 2556
39. Di Lorenzo T.P., Peakman M., and Roep B.O. Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes Clin. Exp. Immunol 148 1 2007 1 16
40. Dorman, J.S., McCarthy, B.J., O'Leary, A.L., Koehler, A.N., 1995. Risk factors for insulin-dependent diabetes. Diabetes in America. National Institute of Diabetes and Digestive and Kidney Diseases pp. 165-177.
41. Doyle H.A., and Mamula M.J. Autoantigenesis: the evolution of protein modifications in autoimmune disease Curr. Opin. Immunol 24 1 2012 112 118
42. DPT-1 Study Group The Diabetes Prevention Trial-type 1 diabetes (DPT-1): implementation of screening and staging of relatives Transpl. Proc 27 6 1995 3377
43. Durinovic-Bello I., Gersuk V.H., Ni C., Wu R., Thorpe J., and Jospe N. Avidity-dependent programming of autoreactive T cells in T1D PLoS ONE 9 5 2014 e98074
44. Eggleton P., Haigh R., and Winyard P.G. Consequence of neo-antigenicity of the 'altered self' Rheumatology 47 5 2008 567 571
45. Eisenbarth G.S. Type I diabetes mellitus: a chronic autoimmune disease N. Engl. J. Med 314 1986 1360 1368
46. Eisenbarth G.S., and Gottlieb P.A. Autoimmune polyendocrine syndromes N. Engl. J. Med 350 20 2004 2068 2079
47. Elding Larsson H., Vehik K., Gesualdo P., Akolkar B., Hagopian W., and Krischer J. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease Pediatr. Diabetes 15 2 2014 118 126
48. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., and Concannon P. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families Diabetes 57 4 2008 1084 1092
49. Falcone M., Lee J., Patstone G., Yeung B., and Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice J. Immunol 161 3 1998 1163 1168
50. Fan Y., Rudert W.A., Grupillo M., He J., Sisino G., and Trucco M. Thymus-specific deletion of insulin induces autoimmune diabetes EMBO J. 28 18 2009 2812 2824
51. Fan Y., Gualtierotti G., Tajima A., Grupillo M., Coppola A., and He J. Compromised central tolerance of ICA69 induces multiple organ autoimmunity J. Autoimmun 53 2014 10 25
52. Foulis A.K., Liddle C.N., Farquharson M.A., Richmond J.A., and Weir R.S. The histopathology of the pancreas in type (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom Diabetologia 29 1986 267 274
53. Gale E.A. The rise of childhood type 1 diabetes in the 20th century Diabetes 51 12 2002 3353 3361
54. Gerling I.C., Serreze D.V., Christianson S.W., and Leiter E.H. Intrathymic islet cell transplantation reduces b-cell autoimmunity and prevents diabetes in NOD/Lt Mice Diabetes 41 1992 1672 1676
55. Gianani R., Campbell-Thompson M., Sarkar S.A., Wasserfall C., Pugliese A., and Solis J.M. Dimorphic histopathology of long-standing childhood-onset diabetes Diabetologia 53 4 2010 690 698
56. Gottlieb P.A., Delong T., Baker R.L., Fitzgerald-Miller L., Wagner R., and Cook G. Chromogranin A is a T cell antigen in human type 1 diabetes J. Autoimmun 50 2014 38 41
57. Greenbaum C.J., Schatz D.A., Cuthbertson D., Zeidler A., Eisenbarth G.S., and Krischer J.P. Islet cell antibody-positive relatives with human leukocyte antigen DQA1∗0102, DQB1∗0602: identification by the Diabetes Prevention Trial-type 1 J. Clin. Endocrinol. Metab 85 3 2000 1255 1260
58. Greenbaum C.J., Schatz D.A., Cuthbertson D., Zeidler A., Eisenbarth G.S., and Krischer J.P. Islet cell antibody-positive relatives with human leukocyte antigen DQA1∗0102, DQB1∗0602: identification by the Diabetes Prevention Trial-type 1 for the Diabetes Prevention Trial - Type 1 Study Group J. Clin. Endocrinol. Metab 85 3 2000 1255 1260
59. Haars R., Kronenberg H., Gallaten W.M., Weissman I.L., Owen F.L., and Hood L. Rearrangement and expression of T cell antigen receptor and g-genes during thymic development J. Exp. Med 164 1 1986 1 24
60. Habib T., Funk A., Rieck M., Brahmandam A., Dai X., and Panigrahi A.K. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant J. Immunol 188 1 2012 487 496
61. Hagopian W.A., Michelsen B., Karlsen A.E., Larsen F., Moody A., and Grubin C.E. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase Diabetes 42 1993 631 636
62. Hansen C.H., Krych L., Buschard K., Metzdorff S.B., Nellemann C., and Hansen L.H. A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice Diabetes 63 8 2014 2821 2832
63. Haskins K., Portas M., Bradley B., Wegmann D., and Lafferty K.J. T-lymphocyte clone specific for pancreatic islet antigen Diabetes 37 1988 1444 1448
64. Herold K.C., Hagopian W., Auger J.A., Poumian-Ruiz E., Taylor L., and Donaldson D. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus N. Engl. J. Med 346 22 2002 1692 1698
65. Hoffenberg E.J., Emery L.M., Barriga K.J., Bao F., Taylor J., and Eisenbarth G.S. Clinical features of children with screening-identified evidence of celiac disease Pediatrics 113 5 2004 1254 1259
66. Howson J.M., Cooper J.D., Smyth D.J., Walker N.M., Stevens H., and She J.X. Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes Diabetes 61 11 2012 3012 3017
67. Huang H.S., Peng J.T., She J.Y., Zhang L.P., Chao C.C., and Liu K.H. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibrium in a Chinese population Hum. Immunol 44 1995 210 219
68. Hulbert C., Riseili B., Rojas M., and Thomas J.W. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice J. Immunol 167 10 2001 5535 5538
69. Husebye E.S., and Anderson M.S. Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis Immunity 32 4 2010 479 487
70. Hyoty H. Enterovirus infections and type 1 diabetes Ann. Med 34 3 2002 138 147
71. Jaberi-Douraki M., Schnell S., Pietropaolo M., and Khadra A. Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes J. Theor. Biol 14 2014 pii: S0022-5193(14)00270-7
72. Jaeger C., Hatziagelaki E., Petzoldt R., and Bretzel R.G. Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects Diabetes Care 24 1 2001 27 32
73. Julier C., Hyer R.N., Davies J., Merlin F., Soularue P., and Briant L. Insulin-IGF2 region encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility Nature 354 1991 155 159
74. Kaprio J., Tuomilehto J., Koskenvuo M., Romanov K., Reunanen A., and Eriksson J. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland Diabetologia 35 1992 1060 1067
75. Karlsen A.E., Hagopian W.A., Grubin C.E., Dube S., Disteche C.M., and Adler D.A. Cloning and primary structure of a human isoform of glutamic acid decarboxylase from chromosome 10 Proc. Natl. Acad. Sci. U.S.A. 88 1991 8337 8341
76. Kastbom A., Strandberg G., Lindroos A., and Skogh T. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project) Ann. Rheum. Dis 63 9 2004 1085 1089
77. Katahira M., Segawa S., Maeda H., and Yasuda Y. Effect of human leukocyte antigen class II genes on acute-onset and slow-onset type 1 diabetes in the Japanese population Hum. Immunol 71 8 2010 789 794
78. Kavvoura F.K., and Ioannidis J.P. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis Am. J. Epidemiol 162 1 2005 3 16
79. Kawasaki E., Yu L., Gianani R., Verge C.F., Babu S., and Bonifacio E. Evaluation of islet cella antigen (ICA) 512/IA-2 autoantibody radioassay using overlapping ICA512/IA-2 constructs J. Clin. Endocrinol. Metab 82 1997 375 380
80. Kennedy G.C., German M.S., and Rutter W.J. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription Nat. Genet 9 1995 293 298
81. Khalil I., D'Auriol L., and Gobet M. A combination of HLA-DQ beta Asp 57-negative and HLA-DQ Arg 52 confers susceptibility to insulin-dependent diabetes mellitus J. Clin. Invest 85 1990 1315 1319
82. Kimpimaki T., Kupila A., Hamalainen A.M., Kukko M., Kulmala P., and Savola K. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study J. Clin. Endocrinol. Metab 86 10 2001 4782 4788
83. Kleffel S., Vergani A., Tezza S., Ben Nasr M., Niewczas M.A., and Wong S. Interleukin-10 + regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens Diabetes 2014 pii: DB-131639
84. LaPorte, R.E., Matsushima, M., Chang, Y.-F., 1995. Prevalence and incidence of insulin-dependent diabetes. Diabetes in America, 37-46.
85. Lee P.T., Putnam A., Benlaga K., Teyton L., Gottlieb P.A., and Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis J. Clin. Invest 110 2002 793 800
86. Liu E., Lee H.S., Aronsson C.A., Hagopian W.A., Koletzko S., and Rewers M.J. Risk of pediatric celiac disease according to HLA haplotype and country N. Engl. J. Med 371 1 2014 42 49
87. Lonnrot M., Korpela K., Knip M., Ilonen J., Simell O., and Korhonen S. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study Diabetes 49 8 2000 1314 1318
88. Lan M.S., Lu J., Goto Y., and Notkins A.L. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma DNA Cell Biol 13 1994 505 514
89. Lucassen A.M., Screaton G.R., Julier C., Elliot T.J., Lathrop M., and Bell J.I. Regulation of insulin gene expression by the IDDM associated, insulin locus haplotype Hum. Mol. Genet 4 4 1994 501 506
90. Lund T., O'Reilly L., Hutchings P., Kanagawa O., Simpson E., and Gravely R. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta chain or normal I-E alpha chain Nature 345 1990 727 729
91. Mahon J.L., Sosenko J.M., Rafkin-Mervis L., Krause-Steinrauf H., Lachin J.M., and Thompson C. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results Pediatr. Diabetes 10 2 2009 97 104
92. Mallone R., Martinuzzi E., Blancou P., Novelli G., Afonso G., and Dolz M. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes Diabetes 56 3 2007 613 621
93. Marron M.P. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups Hum. Mol. Genet 6 8 1997 1275 1282
94. Masson-Bessiere C., Sebbag M., Girbal-Neuhauser E., Nogueira L., Vincent C., and Senshu T. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin J. Immunol 166 6 2001 4177 4184
95. Mathews C.E., Pietropaolo S.L., and Pietropaolo M. Reduced thymic expression of islet antigen contributes to loss of self-tolerance Ann. N. Y. Acad. Sci 1005 2003 412 417
96. Mbunwe E., Van der Auwera B.J., Vermeulen I., Demeester S., Van D.A., and Balti E.V. HLA-A∗24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients Diabetes 62 4 2013 1345 1350
97. Michels A.W. Targeting the trimolecular complex Clin. Immunol 149 3 2013 339 344
98. Michels A.W., Ostrov D.A., Zhang L., Nakayama M., Fuse M., and McDaniel K. Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation J. Immunol 187 11 2011 5921 5930
99. NOD to the development of insulitis in non-obese diabetic mice Nature 345 1990 722 724
100. Morales P., Martinez-Laso J., Martin-Villa J.M., Corell A., Vicario J.L., and Varela P. High frequency of the HLA-DRB1∗0405(Dw15)-DQw8 haplotype in Spaniards and its relationship to diabetes susceptibility Hum. Immunol 32 1991 170 175
101. Morel P.A., Dorman J.S., Todd J.A., McDevitt H.O., and Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against Type I diabetes: a family study Proc. Natl. Acad. Sci. U.S.A. 85 1988 8111 8115
102. Morran M.P., Casu A., Arena V.C., Pietropaolo S., Zhang Y.J., and Satin L.S. Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes Endocrinology 151 6 2010 2528 2537
103. Moscarello M.A., Mastronardi F.G., and Wood D.D. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis Neurochem. Res 32 2 2007 251 256
104. Mziaut H., Trajkovski M., Kersting S., Ehninger A., Altkruger A., and Lemaitre R.P. Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5 Nat. Cell Biol 8 5 2006 435 445
105. Naji A., Silvers S.K., Bellgrau D., and Barker C.F. Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance Science 213 1981 1390 1392
106. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., and Miao D. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice Nature 435 7039 2005 220 223
107. Naumov Y.N., Bahjat K.S., Gausling R., Abraham R., Exley M.A., and Koezuka Y. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets Proc. Natl. Acad. Sci. U.S.A. 98 2001 13838 13843
108. Nepom G.T., and Kwok W.T. Molecular basis for HLA-DQ association in IDDM Diabetes 47 1998 1177 1184
109. Nielsen D.S., Krych L., Buschard K., Hansen C.H., and Hansen A.K. Beyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes FEBS Lett 588 2014 4234 4243
110. Nishimoto H., Kikutani H., Yamamura K., and Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice Nature 328 1987 432 434
111. Noorchashm H., Noorchashm N., Kern J., Rostami S.Y., Barker C.F., and Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice Diabetes 46 6 1997 941 946
112. Orban T., Bundy B., Becker D.J., DiMeglio L.A., Gitelman S.E., and Goland R. Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment Diabetes Care 37 4 2014 1069 1075
113. Orchard T.J., Forman J.S., LaPorte R.E., Ferrell R.E., and Drash A.L. Host and environmental interactions in diabetes mellitus J. Chronic Dis 39 1986 979 999
114. Owerbach D., and Nerup J. Restriction fragment length polymorphism of the insulin gene in diabetes mellitus Diabetes 31 1982 275 277
115. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., and Raghu P.K. Insulin antibodies in insulin-dependent diabetics before insulin treatment Science 222 1983 1337 1339
116. Peakman M., Stevens E.J., Lohmann T., Narendran P., Dromey J., and Alexander A. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4 J. Clin. Invest 104 10 2000 1449 1457
117. Pietropaolo M., and Eisenbarth G.S. Autoantibodies in human diabetes Curr. Dir. Autoimmun 4 2001 252 282
118. Pietropaolo M., and Trucco M. Major histocompatibility locus and other genes that determine the risk of development of Type 1 diabetes mellitus LeRoith D. Taylor S.I. Olefsky J.M. Diabetes Mellitus. A Fundamental and Clinical Text 2000 Lippincott Williams & Wilkins Philadelphia 399 410
119. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y.-L.S., and Martin S. Islet cell autoantigen 69 kDa (ICA69): molecular cloning and characterization of a novel diabetes associated autoantigen J. Clin. Invest 92 1993 359 371
120. Pietropaolo M., Becker D.J., LaPorte R.E., Dorman J.S., Riboni S., and Rudert W.A. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high risk haplotypes Diabetologia 45 2002 66 76
121. Pietropaolo M., Towns R., and Eisenbarth G.S. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes Cold Spring Harb. Perspect. Med 2 10 2012
122. Pugliese A., Gianani R., Moromisato R., Awdeh Z.L., Alper C.A., and Erlich H.A. HLA-DQB1∗0602 is associated with dominant protection from diabetes even among islet cell antibody positive first degree relatives of patients with insulin-dependent diabetes Diabetes 44 1995 608 613
123. Pugliese A., Zeller M., Fernandez A. Jr., Zalcberg L.J., Barlett R.J., and Ricordi C. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes Nat. Genet 15 1997 293 297
124. Pugliese A., Kawasaki E., Zeller M., Yu L., Babu S., and Solimena M. Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1∗0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with Type 1 diabetes J. Clin. Endocrinol. Metab 84 1999 1722 1728
125. Pugliese A., Yang M., Kusmarteva I., Heiple T., Vendrame F., and Wasserfall C. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings Pediatr. Diabetes 15 1 2014 1 9
126. Redondo M.J., and Eisenbarth G.S. Genetic control of autoimmunity in Type I diabetes and associated disorders Diabetologia 45 2002 605 622
127. Redondo M.J., Rewers M., Yu L., Garg S., Pilcher C.C., and Elliott R.B. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study BMJ 318 7185 1999 698 702
128. Reyes A., Wu M., McNulty N.P., Rohwer F.L., and Gordon J.I. Gnotobiotic mouse model of phage bacterial host dynamics in the human gut Proc. Natl. Acad. Sci. U.S.A. 110 2013 20236 20241
129. Richardson S.J., and Horwitz M.S. Is type 1 diabetes "going viral"? Diabetes 63 7 2014 2203 2205
130. Richardson S.J., Leete P., Bone A.J., Foulis A.K., and Morgan N.G. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1 Diabetologia 56 1 2013 185 193
131. Roep B.O., and Tree T.I. Immune modulation in humans: implications for type 1 diabetes mellitus Nat. Rev. Endocrinol 10 4 2014 229 242
132. Rotwein P., Chyn R., Chirgwin J., Cordell B., Goodman H.M., and Permutt M.A. Polymorphism in the 5′-flanking region of the human insulin gene and its possible relation to Type II diabetes Science 213 1981 1117 1120
133. Rowe R.E., Leech N.J., Nepom G.T., and McCulloch D.K. High genetic risk for IDDM in the Pacific Northwest: first report from the Washington State diabetes prediction study Diabetes 43 1994 87 94
134. Schwartz B.D. The major histocompatibility complex and disease susceptibility Bennett J.C. Plum F. Cecil Textbook of Medicine 1996 W.B. Saunders Company Philadelphia 1424 1432
135. Serreze D.V., Chapman H.D., Varnum D.S., Hanson M.S., Reifsnyder P.C., and Richard S.D. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice J. Exp. Med 184 5 1996 2049 2053
136. Serreze D.V., Fleming S.A., Chapman H.D., Richard S.D., Leiter E.H., and Tisch R.M. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice J. Immunol 161 8 1998 3912 3918
137. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., and Delovitch T.L. Regulation of autoimmune disease by natural killer T cells J. Mol. Med 80 2002 290 300
138. She J.-X. Susceptibility to type I diabetes: HLA-DQ and DR revisited Immunol. Today 17 1996 323 329
139. Shi F.D., Flodstrom M., Balasa B., Kim S.H., Van Gunst K., and Strominger J.L. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse Proc. Natl. Acad. Sci. U.S.A. 98 12 2001 6777 6782
140. Silveira P.A., Johnson E., Chapman H.D., Bui T., Tisch R.M., and Serreze D.V. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors Eur. J. Immunol 32 12 2002 3657 3666
141. Skyler J.S., Cefalu W.T., Koudries I.A., Landschulz W.H., Balagtas C.C., and Cheng S.L. Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study Lancet 357 2001 331 335
142. Slattery R.M., Kjer-Nielsen L., Allison J., Charlton B., Mandel T.E., and Miller J.F.A.P. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice Nature 345 1990 724 726
143. Smyth D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., and Yang J.H. Shared and distinct genetic variants in type 1 diabetes and celiac disease N. Engl. J. Med 359 26 2008 2767 2777
144. Smyth D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., and Yang J.H. Shared and distinct genetic variants in type 1 diabetes and celiac disease N. Engl. J. Med 359 26 2008 2767 2777
145. Soderlin M.K., Kastbom A., Kautiainen H., Leirisalo-Repo M., Strandberg G., and Skogh T. Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity Scand. J. Rheumatol 33 3 2004 185 188
146. Solimena M., Folli F., Denis-Donini S., Comi G.C., Pozza G., and De Camilli P. Autoantibodies to glutamic acid decarboxylase in a patient with stiffman syndrome, epilepsy, and Type I diabetes mellitus N. Engl. J. Med 318 1988 1012 1020
147. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., and Armstrong M. Chromogranin A is an autoantigen in type 1 diabetes Nat. Immunol 11 3 2010 225 231
148. Steck A.K., Johnson K., Barriga K.J., Miao D., Yu L., and Hutton J.C. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young Diabetes Care 34 6 2011 1397 1399
149. Szopa T.M., Titchener P.A., Portwood N.D., and Taylor K.W. Diabetes mellitus due to viruses - some recent developments Diabetologia 36 1993 687 695
150. Tang Q., and Bluestone J.A. Regulatory T-cell therapy in transplantation: moving to the clinic Cold Spring Harb. Perspect. Med 3 11 2013
151. Tisch R., and McDevitt H. Insulin-dependent diabetes mellitus Cell 85 1996 291 297
152. Todd J.A., Bell J.I., and McDevitt H.O. HLA-DQb gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus Nature 329 1987 599 604
153. Todd J.A. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes Nat. Genet 39 7 2007 857 864
154. van Lummel M., Duinkerken G., van Veelen P.A., de Ru A., Cordfunke R., and Zaldumbide A. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes Diabetes 63 1 2014 237 247
155. Vang T., Congia M., Macis M.D., Musumeci L., Orru V., and Zavattari P. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant Nat. Genet 37 12 2005 1317 1319
156. Vehik K., Hamman R.F., Lezotte D., Norris J.M., Klingensmith G., and Bloch C. Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth Diabetes Care 30 3 2007 503 509
157. Verge C.F., Gianani R., Yu L., Pietropaolo M., Smith T., and Jackson R.A. Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes Diabetes 44 10 1995 1176 1179
158. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., and Jackson R.A. Prediction of type I diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512bdc/IA-2 autoantibodies Diabetes 45 1996 926 933
159. Vong A.M., Daneshjou N., Norori P.Y., Sheng H., Braciak T.A., and Sercarz E.E. Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igmu(null) mice after polyclonal B cell reconstitution J. Transl. Med 9 2011 101
160. Wagener D.K., Sacks J.M., LaPorte R.E., and MacGregor J.M. The Pittsburgh study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM Diabetes 31 1982 136 144
161. Warram J.H., Krolewski A.S., Gottlieb M.S., and Kahn C.R. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers N. Engl. J. Med 311 1984 149 152
162. Warram J.H., Rich S.S., and Krolewski A.S. Epidemiology and genetics of diabetes mellitus Kahn C.R. Weir G.C. Joslin's Diabetes Mellitus 1994 Lea and Febiger Philadelphia 201
163. Wasmeier C., and Hutton J.C. Molecular cloning of phogrin, a protein tyrosyne phosphatase homologue localized to insulin secretory granule membranes J. Biol. Chem 271 30 1996 18161 18170
164. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., and Stonebraker A.C. Innate immunity and intestinal microbiota in the development of Type 1 diabetes Nature 455 7216 2008 1109 1113
165. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., and Gottlieb P. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes Proc. Natl. Acad. Sci. U.S.A. 104 43 2007 17040 17045
166. Wenzlau J.M., Moua O., Liu Y., Eisenbarth G.S., Hutton J.C., and Davidson H.W. Identification of a major humoral epitope in Slc30A8 (ZnT8) Ann. N. Y. Acad. Sci 1150 2008 252 255
167. Wijesekara N., Chimienti F., and Wheeler M.B. Zinc, a regulator of islet function and glucose homeostasis Diabetes Obes. Metab 11 Suppl. 4 2009 202 214 202-214
168. Wijesekara N., Dai F.F., Hardy A.B., Giglou P.R., Bhattacharjee A., and Koshkin V. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion Diabetologia 53 8 2010 1656 1668
169. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., and Exley M. Extreme Th1 bias of invariant Va24JaQ T cells in type 1 diabetes Nature 391 1998 177 181
170. Wilson S.B., Kent S.C., Horton H.F., Hill A.A., Bollyky P.L., and Hafler D.A. Multiple differences in gene expression in regulatory Va24JaQ T cells from identical twins discordant for type I diabetes Proc. Natl. Acad. Sci. U.S.A. 97 2000 7411 7416
171. Winer S., Tsui H., Lau A., Song A., Li X., and Cheung R.K. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive Nat. Med 9 2003 198 205
172. Wong F.S., Wen L., Tang M., Ramanathan M., Visintin I., and Daugherty J. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse Diabetes 53 10 2004 2581 2587
173. Wucherpfennig K.W., and Eisenbarth G.S. Type 1 diabetes Nat. Immunol 2 9 2001 767 768
174. Xu P., Wu Y., Zhu Y., Dagne G., Johnson G., and Cuthbertson D. Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes Diabetes Care 33 12 2010 2508 2513
175. Yu L., Liu Y., Miao D., Wenzlau J., Davidson H., and Hutton J. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination J. Immunol. Meth 353 1-2 2010 20 23
176. Zhang L., Crawford F., Yu L., Michels A., Nakayama M., and Davidson H.W. Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes Proc. Natl. Acad. Sci. U.S.A. 111 7 2014 2656 2661
177. Zhang X.M., Wang H.Y., Luo Y.Y., and Ji L.N. HLA-DQ, DR allele polymorphism of type 1 diabetes in the Chinese population: a meta-analysis Chin. Med. J. 122 8 2009 980 986
178. Zipris D., Lien E., Nair A., Xie J.X., Greiner D.L., and Mordes J.P. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat J. Immunol 178 2 2007 693 701